Brain Blood Flow Gives Clues to Treating DepressionAugust 09, 2007Usefulness of Established Molecular Imaging/Nuclear Medicine Approaches Examine Brain Dysfunction, Provide Information on Treatment Possibilities, Say Authors in August Journal of Nuclear Medicine RESTON, Va.-The usefulness of established molecular imaging/nuclear medicine approaches in identifying the "hows" and "whys" of brain dysfunction and its potential in providing immediately useful information in treating depression are emphasized in a study in the August Journal of Nuclear Medicine. "Individuals in a depressed emotional state have impaired cerebral (brain) blood flow," explained Omer Bonne, head of inpatient psychiatry and associate professor in the Department of Psychiatry at Hadassah-Hebrew University Medical Center in Jerusalem, Israel. "Clinical improvement in depression is accompanied by diverse changes in cerebral blood flow, according to whether patients are treated with medication or electroconvulsive treatment," he noted. "We found that antidepressant medicines normalized decreased brain blood flow usually seen in patients with depression, while electroconvulsive treatment was associated with additional decreases in blood flow," he reported. "Currently, clinical psychiatry is based almost solely on subjective observer-based judgment. Our findings suggest that objective imaging evaluations could support subjective clinical decisions," he said.
Using SPECT (single photon emission computed tomography)-a molecular imaging/nuclear medicine procedure in which injected radiotracers are utilized to produce three-dimensional, computer-reconstructed images that reveal information about both structure and function-investigators confirmed already published findings that cerebral blood flow in depressed patients is lower than in healthy control subjects, especially in frontal, limbic and subcortical brain regions. "We wanted to see whether improvement in clinical depression is accompanied by changes-increases-in cerebral blood flow," he said. "We found that cerebral blood flow increased only in patients whose depression improved. In contrast, cerebral blood flow remained unchanged in patients whose depressed condition persisted," detailed Bonne. Depression is a serious and debilitating-yet treatable-disease that affects every aspect of a person's health. Estimates indicate that 19 million Americans are affected by depression each year, along with their family members, friends and co-workers. Depression may be related to a chemical imbalance in the brain that makes it hard for the cells to communicate with one another. A variety of antidepressant medications and psychotherapies are used to treat depression. Sometimes electroconvulsive therapy-applying an electric current briefly to produce a seizure-is useful, especially for those whose depression is severe or life threatening or for whom repeated treatment trials with antidepressant drugs failed. "Interestingly, patients' response to two different classes of antidepressant medicines that target different neurotransmitters is associated with a similar improvement in cerebral blood flow," he noted. "However, cerebral blood flow continued to deteriorate in patients who responded to electroconvulsive therapy," added Bonne, who helped implement functional brain imaging research in psychiatry at Hadassah. Israeli researchers studied 33 depressed patients and 25 healthy control subjects with SPECT and the radiotracer 99mTc-HMPAO. "Our findings may aid in elucidating the mechanism of depression and its treatment," said Bonne. "There may be more than one mechanism responsible for the development of depression and for mediating response to its treatment," he added. Additional research could examine whether it's possible to use functional imaging techniques to determine which patients would benefit from drug treatment and which would respond better to electroconvulsive therapy, explained Bonne. Future research should also examine the differences in brain blood flow in patients at later time points, he said. "99mTc-HMPAO SPECT Study of Cerebral Perfusion After Treatment With Medication and Electroconvulsive Therapy in Major Depression" appears in the August issue of the Journal of Nuclear Medicine, which is published by SNM, the world's largest molecular imaging and nuclear medicine society. Co-authors include Yoav Kohn and Bernard Lerer, Department of Psychiatry, and Nanette Freedman, Hava Lester, Yodphat Krausz and Roland Chisin, Department of Medical Biophysics and Nuclear Medicine, at Hadassah-Hebrew University Medical Center in Jerusalem, Israel. SNM | |||||||||||||||||||||
|
Related Depression Current Events and Depression News Articles Vitamin B does not slow cognitive decline in Alzheimer's A clinical trial led by Paul S. Aisen, M.D., professor of neurosciences at the University of California, San Diego School of Medicine, showed that high-dose vitamin B supplements did not slow the rate of cognitive decline in patients with mild to moderate Alzheimer disease. Insomnia in women with breast cancer linked to heart rate dysregulation A study in the October 15 issue of the Journal of Clinical Sleep Medicine shows that respiratory sinus arrhythmia (RSA) is a significant predictor of insomnia in women with breast cancer and confirmed that longer nocturnal wake episodes were associated with a flatter diurnal cortisol slope. Astrocytes and synaptic plasticity By mopping up excess neurotrophic factor from neuronal synapses, astrocytes may finely tune synaptic transmission to affect processes such as learning and memory, say Bergami et al. Astrocytes and synaptic plasticity By mopping up excess neurotrophic factor from neuronal synapses, astrocytes may finely tune synaptic transmission to affect processes such as learning and memory, say Bergami et al. Has a new era of reinstitutionalization in mental health care begun? A retrospective analysis of hospital episode statistics, involuntary admissions under the Mental Health Act 1983, and the number of psychiatric beds in England 1996-2006. Compassion meditation may improve physical and emotional responses to psychological stress Data from a new study suggests that individuals who engage in compassion meditation may benefit by reductions in inflammatory and behavioral responses to stress that have been linked to depression and a number of medical illnesses. Millisecond brain signals predict response to fast-acting antidepressant Images of the brain's fastest signals reveal an electromagnetic marker that predicts a patient's response to a fast-acting antidepressant, researchers have discovered. Bullying of teenagers online is common, UCLA psychologists report Nearly three in four teenagers say they were bullied online at least once during a recent 12-month period, and only one in 10 reported such cyber-bullying to parents or other adults, according to a new study by UCLA psychologists. Getting help for depression and anxiety has significant long-term benefits According to the Mood Disorder Society of Canada, about 1.3 million Canadians suffer from depression. Smoking increases depression in women, study reveals Researchers from the University of Melbourne and Barwon Health assessed a group of 1043 Australian women, whose health had been monitored for a decade as part of the Geelong Osteoporosis Study. More Depression Current Events and Depression News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||